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Mantle cell lymphoma (MCL) is a subtype of B-cell non-Hodgkin's lymphoma. Most cases of MCL have
extranodal involvement at the time of the initial diagnosis; however, endobronchial involvement is rare.
An 87-year-old man was referred to our hospital because of dyspnea on exertion. A chest CT revealed
diffuse irregular wall thickening of the trachea and bilateral bronchi. A bronchoscopy revealed a diffuse
irregular surface of the tracheal and bilateral bronchial mucosa and polyposis-like lesions. He was
diagnosed as having MCL based on an endobronchial biopsy, and the diagnosis was conﬁrmed using
immunohistochemical staining.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mantle cell lymphoma (MCL) is a subtype of B-cell non-Hodg-
kin's lymphoma (NHL). MCL represents about 4%e6% of all lym-
phomas [1,2]. The diagnosis of MCL is based on biopsy results that
show a distinctive morphology, and immunohistochemical staining
reveals positivity for CD5 and CD20 as B-cell markers. Furthermore,
the overexpression of cyclin D1 protein because of the chromo-
somal translocation t (11; 14) (q13:q32) of the CCND1 gene is
characteristic of MCL [3]. Most patients are in their 60 s at the time
of diagnosis, with a male predominance. Almost all cases are
already advanced at the time of diagnosis with stage III or IV dis-
eases and have extranodal involvement, such as the gastrointes-
tinal tract, spleen with splenomegaly, bone marrow, liver,
Waldeyer's ring, skin, lacrimal glands and central nervous system
[4,5]. However, endobronchial involvement of MCL is rare, and the
bronchoscopic ﬁndings for MCL are uncertain. We report a case of
endobronchial MCL in which a bronchoscopy was performed
resulting in a diagnosis based on endobronchial biopsy.
2. Case report
An 87-year-old man was referred to our hospital for dyspnea ony Medicine, School of Medi-
Sagamihara, Kanagawa 252-
o).
r Ltd. This is an open access articleexertion. He was a never smoker and had no complications. His
ECOG performance status was 1. Upon physical examination, an
enlarged left supraclavicular lymph node was detected. A chest CT
examination revealed diffuse irregular wall thickening at the tra-
chea and bilateral bronchi (Fig. 1), atelectasis of the right middle
lobe because of right middle bronchial wall thickening, an enlarged
lymph node in the left supraclavicular and right axillary area, and
splenomegaly. Complete blood counts revealed a white blood cell
count of 4800/mm3, a hemoglobin level of 10.8 g/dL, a platelet
count of 132,000/mm3, an absolute neutrophil count of 2822/mL
(58.8%), and a lymphocyte count of 989/mL (20.6%). Moreover, large
atypical lymphocytes were detected (8%). A bronchoscopy revealed
diffuse irregular surface of the tracheal and bilateral bronchial
mucosa and polyposis-like lesions (Fig. 2). An endobronchial biopsy
was performed for the mucosa of trachea and the inlet of the right
upper lobe and middle lobe. All biopsy specimens revealed atypical
cells with a high nuclear cytoplasmic ratio and irregular nuclei
forming sheet-like lesions. These morphologic ﬁndings were
compatible with a low grade lymphoma, such as MCL (Fig. 3A and
B). On immunohistochemical staining, these atypical cells were
found to be positive for CD5, CD20, CD79a, and Cyclin D1 but
negative for CD3, CD10, CD21, and CD138 (Fig. 3C and D). Therefore,
the diagnosis of MCL was conﬁrmed based on the morphology and
immunohistochemical ﬁndings especially positivity for CD5 and
Cyclin D1. After the diagnosis of MCL, best-supportive care was
selected as the treatment of choice, and he was transferred to
another hospital.under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
Fig. 1. Chest CT shows diffuse irregular wall thickening at the trachea (A) and bilateral bronchi (B).
Fig. 2. Bronchoscopy shows diffuse irregular surface of the tracheal and bilateral bronchial mucosa and polyposis-like lesions. (A) Trachea. (B) Bronchus of right upper lobe. (C)
Bronchus intermedius. (D) Left secondary carina.
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MCL has a high frequency of extranodal involvement, but
endobronchial involvement is rare [4] [5]. To the best of our
knowledge, only two cases of MCL with endobronchial involve-
ment have been previously reported [6,7]. A previous report that
evaluated extranodal sites of MCL based on CT examinations
revealed that pulmonary involvement was present in 7% of the
cases at the time of diagnosis, but endobronchial involvement was
not detected [8]. A bronchoscopy was not routinely performed at
the time of the initial diagnosis of NHL except in one case with
abnormal ﬁndings on a chest CT examination. Therefore, the cor-
rect frequency of endobronchial involvement in patients with NHLincluding MCL is uncertain. 18F-ﬂuoro-2-deoxyglucose positron
emission tomography (FDG-PET) is useful for the detection of
extranodal sites of malignant lymphoma. Furthermore, FDG-PET
has a high sensitivity in detecting both nodal and extranodal dis-
ease in patients with MCL [9]. Although, the present case did not
undergo FDG-PET, the usefulness of FDG-PET for the detection of
the endobronchial involvement of MCL should be evaluated in
greater detail.
Endobronchial lymphoma is categorized into two patterns:
diffuse submucosal inﬁltration (type I) and localized solitary mass
(type II) [10,11]. Interestingly, the previous two cases and the
present case all exhibited a type I pattern. Several possible
mechanisms of endobronchial metastasis have been reported such
Fig. 3. Pathological ﬁndings of endobronchial biopsy. (A) Atypical cells localized at the under of bronchial mucosa (H&E staining, 100). (B) Atypical cells with a high nuclear
cytoplasmic ratio and irregular nuclei formed sheet like lesions (H&E staining, 400). (C) Immunohistochemical staining revealed positivity for CD5 (200). (D) Immunohisto-
chemical staining revealed positivity for Cyclin D1 (200).
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bronchial invasion from a mediastinal mass, lymphatic spread to
peribronchial connective tissue, transbronchial aspiration of tu-
mor emboli, and direct hematogenous metastasis [12,13]. The
present case did not have pulmonary parenchymal involvement or
mediastinal involvement; on the other hand, an enlarged super-
ﬁcial lymph node and large atypical lymphocytes in the peripheral
blood were noted. These results suggest that lymphatic and/or
hematogenous metastasis may have caused the endobronchial
involvement in the present case.
The diagnosis of MCL is made based on a biopsy of lymph nodes,
tissue, bone marrow, or blood phenotype [4]. Most cases display a
typical morphology of inﬁltrating small-to medium-sized cells and
positive immunohistochemistry results, especially for cyclinD1 [3].
In the present study, a histopathological diagnosis based on an
endobronchial biopsy was possible, indicating that endobronchial
biopsy could be a useful diagnostic procedure if endobronchial
involvement is suspected.
In conclusion, the endobronchial involvement of MCL is rare.
Bronchoscopic ﬁndings revealed a diffuse irregular surface of the
tracheal and bilateral bronchial mucosa and polyposis like lesions.
A histopathological diagnosis can be made based on an endo-
bronchial biopsy. Trachea and bronchial wall ﬁndings on chest CT
should be carefully examined at NHL cases.
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